A fragment corresponding to amino acids Lys
169 to Ala
225 (LAPTM4B; Molecular weight = 7.5 kDa) located at the carboxy-terminal end of the bovine LAPTM4B was used to generate a glutathione S-transferase fusion protein (GST Gene Fusion System; GE Healthcare Life Sciences) to produce specific polyclonal antibodies. To increase the molecular weight of LAPTM4B recombinant protein fragment and thus facilitate down-stream purification procedures, a DNA construct that included a tandem repeat of Lys
169 to Ala
225 (LA)
2-LAPTM4B fragments cloned at the carboxy-terminal end of the GST was generated. A set of forward (5′-AAGGGTTACTTGATTAGCTGTGTTTGG-3′) and reverse (5′-GGCAGACACGTACGGGGGC-3′) primers that incorporated
BamHI (forward primer) and
EcoRI (reverse primer) restriction sites were designed from the LAPTM4B cDNA to generate the first LAPTM4B fragment. The same set of primers that incorporated an
EcoRI (forward primer) and
SalI (reverse primer) were used to generate the second LAPTM4B fragment. The LAPTM4B fragments were amplified by PCR using the Expand High Fidelity polymerase (Roche Molecular Biochemicals) according to the manufacturer’s protocol. The fragments were isolated after electrophoresis, digested with either
BamHI and
EcoRI (for the first fragment), or
EcoRI and
SalI (for the second fragment). The first fragment was subcloned into the pGEX-2 T vector (GE Healthcare Life Sciences) in frame with the GST coding region, as described previously [
28]. The second fragment was then subcloned down-stream of the GST-LAPTM4B first fragment, and the resulting plasmid sequenced to confirm its integrity. Protease-deficient
E. coli BL-21 (GE Healthcare Life Sciences) were transformed with the (LA)
2-LAPTM4B/pGEX-2 T construct, and expression of recombinant (LA)
2-LAPTM4B/GST fusion protein was induced with 0.1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) for 6 hours. Proteins from bacterial extracts were obtained after sonication as previously described [
28]. The (LA)
2-LAPTM4B/GST-fusion protein was purified by affinity on glutathione-Sepharose beads (GE Healthcare Life Sciences), and digested with thrombin (10units/1 mg of fusion protein) to release the tandem (LA)
2-LAPTM4B fragment. Proteins were resolved by one-dimensional SDS-PAGE, transferred onto nitrocellulose membrane (0.45 μm Hybond C; GE Healthcare Life Sciences), and stained with Ponceau S red. The tandem (LA)
2-LAPTM4B band (MW = 15.3 kDa) was cut and used to immunize a rabbit as previously described [
28]. Preceeding immunization, the identity of the purified (LA)
2-LAPTM4B fragment was verified by liquid chromatography-tandem mass spectrometry (Eastern Quebec Proteomics Center, Laval University, Quebec, Canada). Polyclonal antibodies against bovine LAPTM4B were validated by immunoblotting using the GST-affinity purified recombinant (LA)
2-LAPTM4B.